{"id":282494,"date":"2026-10-01T09:54:57","date_gmt":"2026-10-01T04:24:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282494"},"modified":"2026-10-01T09:54:57","modified_gmt":"2026-10-01T04:24:57","slug":"why-dr-lal-pathlabs-share-consecutive-price-fall-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/","title":{"rendered":"Dr. Lal Pathlabs (LALPATHLAB) Share Price Fall Streak Extends to Second Straight Session Decline"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs (LALPATHLAB)<\/a> share price fell to Rs 1,947.15 today, down 2.04% from the previous close. Market cap was Rs 32,833.75 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Dr. Lal Pathlabs Share Price Fall Streak now covers the second straight session, with the stock trading at Rs 1,947.15 after a cumulative 0.46% decline across the run. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established. The move keeps Dr. Lal Pathlabs Share Price Fall Streak in focus because consecutive lower closes matter more than a single-day move: they show that the decline has persisted across sessions rather than appearing as an isolated swing.<\/p>\n<p>Dr. Lal Pathlabs carries a market capitalisation of Rs 32,833.75 Cr, so the streak is meaningful for a large listed healthcare business rather than a smaller counter. For a reader tracking Dr. Lal Pathlabs Share Price Fall Streak, the key point is that the latest move sits within a broader run of lower closes and not a one-off intraday dip. That makes the current Dr. Lal Pathlabs Share Price Fall Streak worth reading alongside valuation, sector comparison and peer positioning.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Fall_Streak_Consecutive_Decline_Analysis\" title=\"Dr. Lal Pathlabs (LALPATHLAB) Share Price Fall Streak: Consecutive Decline Analysis\">Dr. Lal Pathlabs (LALPATHLAB) Share Price Fall Streak: Consecutive Decline Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#What_the_Consecutive_Declines_Show\" title=\"What the Consecutive Declines Show\">What the Consecutive Declines Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Dr_Lal_Pathlabs_LALPATHLAB_Fundamental_Analysis\" title=\"Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis\">Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Why_Investors_Are_Watching_Dr_Lal_Pathlabs\" title=\"Why Investors Are Watching Dr. Lal Pathlabs\">Why Investors Are Watching Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#About_Dr_Lal_Pathlabs\" title=\"About Dr. Lal Pathlabs\">About Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\" title=\"Track Dr. Lal Pathlabs Share Price on Univest\">Track Dr. Lal Pathlabs Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Why_is_Dr_Lal_Pathlabs_Share_Price_Fall_Streak_in_focus_today\" title=\"Why is Dr. Lal Pathlabs Share Price Fall Streak in focus today?\">Why is Dr. Lal Pathlabs Share Price Fall Streak in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#What_is_the_current_Dr_Lal_Pathlabs_Share_Price\" title=\"What is the current Dr. Lal Pathlabs Share Price?\">What is the current Dr. Lal Pathlabs Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#How_much_did_Dr_Lal_Pathlabs_share_price_fall_today\" title=\"How much did Dr. Lal Pathlabs share price fall today?\">How much did Dr. Lal Pathlabs share price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#What_does_the_latest_valuation_say_about_Dr_Lal_Pathlabs_Share_Price_Fall_Streak\" title=\"What does the latest valuation say about Dr. Lal Pathlabs Share Price Fall Streak?\">What does the latest valuation say about Dr. Lal Pathlabs Share Price Fall Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#How_does_Dr_Lal_Pathlabs_compare_with_healthcare_peers\" title=\"How does Dr. Lal Pathlabs compare with healthcare peers?\">How does Dr. Lal Pathlabs compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#What_are_the_key_fundamental_numbers_for_Dr_Lal_Pathlabs\" title=\"What are the key fundamental numbers for Dr. Lal Pathlabs ?\">What are the key fundamental numbers for Dr. Lal Pathlabs ?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#What_does_the_sector_benchmark_show_for_Dr_Lal_Pathlabs_Share_Price_Fall_Streak\" title=\"What does the sector benchmark show for Dr. Lal Pathlabs Share Price Fall Streak?\">What does the sector benchmark show for Dr. Lal Pathlabs Share Price Fall Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-consecutive-price-fall-2026\/#Should_investors_track_Dr_Lal_Pathlabs_Share_Price_on_Univest\" title=\"Should investors track Dr. Lal Pathlabs Share Price on Univest?\">Should investors track Dr. Lal Pathlabs Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Fall_Streak_Consecutive_Decline_Analysis\"><\/span><strong>Dr. Lal Pathlabs (LALPATHLAB) Share Price Fall Streak: Consecutive Decline Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,947.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,987.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 40.45 (-2.04%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,973.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,973.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,937.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,833.75 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Dr. Lal Pathlabs Share Price Fall Streak continued as the stock traded at Rs 1,947.15, down Rs 40.45 or 2.04% from the previous close of Rs 1,987.60. The session opened at Rs 1,973.70, touched a high of Rs 1,973.70 and a low of Rs 1,937.10, with the last trade sitting much closer to the lower end of that range. The market capitalisation stood at Rs 32,833.75 Cr, which places the company in the Large Cap category and gives the move a visible impact on headline valuation. For Dr. Lal Pathlabs Share Price Fall Streak, the key takeaway is that the stock did not recover back toward the opening level during the session. Dr. Lal Pathlabs Share Price Fall Streak also matters because the latest trade extends the second straight session of lower closes, so the move should be read as a short run of weakness rather than a single isolated slide. The price action now leads naturally into the valuation discussion that follows.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Consecutive_Declines_Show\"><\/span><strong>What the Consecutive Declines Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal Pathlabs Share Price Fall Streak is the main lens for this update because the stock has now closed lower for the second straight session, with a cumulative change of -0.46% from the streak start base price of Rs 1,956.15. That cumulative figure is much smaller than the latest daily decline, which tells readers that the two sessions have not moved in the same magnitude. Instead, the pattern shows a continued drift lower across sessions. Univest figures confirm the price action, but they do not point to a specific company trigger. For Dr. Lal Pathlabs Share Price Fall Streak, that distinction matters: the streak is about persistence, not just the size of one trading day. The business is still the same company with the same earnings base and book value base, but the market price has moved lower, which is what changes the share-price lens.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_LALPATHLAB_Fundamental_Analysis\"><\/span><strong>Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,833.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">61.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 155.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.03%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Dr. Lal Pathlabs (LALPATHLAB) fundamental metrics show P\/E 61.56x, P\/B 12.77x, ROE 22.37%, ROCE 29.56%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Dr. Lal Pathlabs has a market capitalisation of Rs 32,833.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 61.56x, P\/B at 12.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.03%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 45.98x, median ROE of 13.01%, median ROCE of 15.84%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">61.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">99.66x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.96x to 1,608.25x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.61x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.01%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.87%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,833.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 581.1 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11,299.25 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Dr. Lal Pathlabs (LALPATHLAB) operates in the Healthcare sector, within the Hospital &amp; Healthcare Services industry.<\/p>\n<p>Dr. Lal Pathlabs (LALPATHLAB) has a P\/E ratio of 61.56x, which is above the benchmark median of 45.98x, a difference of +33.88%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Dr. Lal Pathlabs (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.01%, a difference of +71.94%. Dr. Lal Pathlabs (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.84%, a difference of +86.62%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Apollo Hospitals Enterprise<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APOLLOHOSP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,25,119.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.73<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/manipalhos\/manipal-health-enterpri-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>MANIPAL HEALTH ENTERPRI L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MANIPALHOS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98,508.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">104.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Max Healthcare Institute<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MAXHEALTH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">95,768.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/asterdm\/aster-dm-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aster DM Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTERDM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">64,094.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">190.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Fortis Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FORTIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">61,831.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.07<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Dr. Lal Pathlabs (LALPATHLAB) has a P\/E ratio of 61.56x compared with the displayed peer median of 62.11x. The comparison is relative and should not be read as a recommendation. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Dr. Lal Pathlabs (LALPATHLAB) has a market capitalisation of Rs 32,833.75 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Dr_Lal_Pathlabs\"><\/span><strong>Why Investors Are Watching Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Dr. Lal Pathlabs Share Price Fall Streak shows a second straight session of lower closes, which keeps the stock in focus for traders tracking price action.<\/li>\n<li>The current trade at Rs 1,947.15 sits below the previous close, making the move relevant for anyone watching Dr. Lal Pathlabs Share Price Today.<\/li>\n<li>The company\u2019s P\/E of 61.56 and P\/B of 12.77 remain well above the sector median, so valuation remains central to Dr. Lal Pathlabs Fundamental Analysis.<\/li>\n<li>ROE of 22.37% and ROCE of 29.56% still compare favourably with the same-industry benchmark, which keeps the stock interesting for stock analysis.<\/li>\n<li>The healthcare peer set shows mixed valuation profiles, so Dr. Lal Pathlabs Share Price Fall Streak can be read alongside peer comparison rather than in isolation.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Dr_Lal_Pathlabs\"><\/span><strong>About Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal Pathlabs operates in Healthcare within the Hospital &amp; Healthcare Services industry. The business is known for diagnostic and pathology services, which makes its earnings profile different from a hospital operator even though it sits in the same broad sector benchmark. For Dr. Lal Pathlabs Share Price Fall Streak, that distinction matters because investors are not just looking at one-day price movement; they are also weighing the company\u2019s premium valuation, profitability ratios and large-cap position. The latest share-price move does not change what the company does, but it does change how the market reads the stock against its sector peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\"><\/span><strong>Track Dr. Lal Pathlabs Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs (LALPATHLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Track Dr. Lal Pathlabs Share Price on Univest to follow the latest share price, market capitalisation, valuation ratios and 52-week levels in one place. Dr. Lal Pathlabs Share Price Fall Streak can be monitored alongside fundamental analysis, peer comparison and sector context, all with a clean stock overview for faster reading.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Dr_Lal_Pathlabs_Share_Price_Fall_Streak_in_focus_today\"><\/span><strong>Why is Dr. Lal Pathlabs Share Price Fall Streak in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs Share Price Fall Streak is in focus because the stock has closed lower for the second straight session. The latest trade was Rs 1,947.15, down 2.04% from the previous close.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Dr_Lal_Pathlabs_Share_Price\"><\/span><strong>What is the current Dr. Lal Pathlabs Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The current Dr. Lal Pathlabs Share Price is Rs 1,947.15. It is below the previous close of Rs 1,987.60, which keeps the latest price action under watch. The stock moved 2.04% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Dr_Lal_Pathlabs_share_price_fall_today\"><\/span><strong>How much did Dr. Lal Pathlabs share price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs share price fell by Rs 40.45, or 2.04%, in the latest session. That move extended the second straight session of lower closes and kept the streak in view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_latest_valuation_say_about_Dr_Lal_Pathlabs_Share_Price_Fall_Streak\"><\/span><strong>What does the latest valuation say about Dr. Lal Pathlabs Share Price Fall Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs Share Price Fall Streak leaves the stock at a P\/E of 61.56 and a P\/B of 12.77. Those are still premium multiples versus the sector median, even after the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_compare_with_healthcare_peers\"><\/span><strong>How does Dr. Lal Pathlabs compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs Share Price Fall Streak still sits alongside peers such as Apollo Hospitals, Max Healthcare and Fortis. Its ROE and ROCE remain stronger than some peers, while its valuation remains elevated.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_fundamental_numbers_for_Dr_Lal_Pathlabs\"><\/span><strong>What are the key fundamental numbers for Dr. Lal Pathlabs ?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs reports EPS of Rs 32.29, book value of Rs 155.67 and dividend yield of 1.03%. ROE is 22.37% and ROCE is 29.56%, which support the fundamental context behind the stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_sector_benchmark_show_for_Dr_Lal_Pathlabs_Share_Price_Fall_Streak\"><\/span><strong>What does the sector benchmark show for Dr. Lal Pathlabs Share Price Fall Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Dr. Lal Pathlabs Share Price Fall Streak is still above the sector median on P\/E and P\/B. The company\u2019s ROE and ROCE are also above the same-industry median, which keeps the comparison relevant.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Dr_Lal_Pathlabs_Share_Price_on_Univest\"><\/span><strong>Should investors track Dr. Lal Pathlabs Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors tracking Dr. Lal Pathlabs Share Price can use Univest to watch price levels, valuation ratios and sector context together. The streak is best read with fundamentals rather than in isolation.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Dr. Lal Pathlabs Share Price Fall Streak in focus today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs Share Price Fall Streak is in focus because the stock has closed lower for the second straight session. The latest trade was Rs 1,947.15, down 2.04% from the previous close.\"}},{\"@type\":\"Question\",\"name\":\"What is the current Dr. Lal Pathlabs Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The current Dr. Lal Pathlabs Share Price is Rs 1,947.15. It is below the previous close of Rs 1,987.60, which keeps the latest price action under watch. The stock moved 2.04% lower during the session.\"}},{\"@type\":\"Question\",\"name\":\"How much did Dr. Lal Pathlabs share price fall today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs share price fell by Rs 40.45, or 2.04%, in the latest session. That move extended the second straight session of lower closes and kept the streak in view.\"}},{\"@type\":\"Question\",\"name\":\"What does the latest valuation say about Dr. Lal Pathlabs Share Price Fall Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs Share Price Fall Streak leaves the stock at a P\/E of 61.56 and a P\/B of 12.77. Those are still premium multiples versus the sector median, even after the decline.\"}},{\"@type\":\"Question\",\"name\":\"How does Dr. Lal Pathlabs compare with healthcare peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs Share Price Fall Streak still sits alongside peers such as Apollo Hospitals, Max Healthcare and Fortis. Its ROE and ROCE remain stronger than some peers, while its valuation remains elevated.\"}},{\"@type\":\"Question\",\"name\":\"What are the key fundamental numbers for Dr. Lal Pathlabs ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs reports EPS of Rs 32.29, book value of Rs 155.67 and dividend yield of 1.03%. ROE is 22.37% and ROCE is 29.56%, which support the fundamental context behind the stock.\"}},{\"@type\":\"Question\",\"name\":\"What does the sector benchmark show for Dr. Lal Pathlabs Share Price Fall Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr. Lal Pathlabs Share Price Fall Streak is still above the sector median on P\/E and P\/B. The company\u2019s ROE and ROCE are also above the same-industry median, which keeps the comparison relevant.\"}},{\"@type\":\"Question\",\"name\":\"Should investors track Dr. Lal Pathlabs Share Price on Univest?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors tracking Dr. Lal Pathlabs Share Price can use Univest to watch price levels, valuation ratios and sector context together. The streak is best read with fundamentals rather than in isolation.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Pathlabs Share Price fell 2.04% to Rs 1,947.15 today, extending the decline to a second straight session (-0.46% across the streak). Market cap stands at Rs 32,833.75 crore.<\/p>\n","protected":false},"author":35,"featured_media":282492,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-282494","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["282492"],"rank_math_title":["Dr. Lal Pathlabs Share Price Fall Streak: Key View"],"rank_math_description":["Dr. Lal Pathlabs Share Price Fall Streak shows a 2.04% decline to Rs 1,947.15. Read the price move, valuation and peer context."],"rank_math_focus_keyword":["Dr. Lal Pathlabs Share Price Fall Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Fall_Streak_Extends_to_Second_Straight_Session_Decline_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=282494"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282494\/revisions"}],"predecessor-version":[{"id":282495,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282494\/revisions\/282495"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/282492"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=282494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=282494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=282494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}